WallStreetZenWallStreetZen

NASDAQ: CORT
Corcept Therapeutics Inc Stock Ownership - Who owns Corcept Therapeutics?

OverviewForecastEarningsRevenueDividendOwnership

Insider buying vs selling

Have Corcept Therapeutics Inc insiders been buying or selling?

Buy
Sell
NameRoleDateSharesPriceValue
James N. WilsonDirector2026-10-15300$116.30
$34.89kSell
James N. WilsonDirector2026-10-153,046$115.39
$351.47kSell
James N. WilsonDirector2026-10-156,654$114.48
$761.72kSell
Joseph Douglas LyonCTO;CAO2026-10-025,833$19.26
$112.34kBuy
Joseph Douglas LyonCTO;CAO2026-10-023,357$13.56
$45.52kBuy
Joseph Douglas LyonCTO;CAO2026-10-024,446$115.70
$514.39kSell
Sean MaduckOfficer2026-10-028,744$116.55
$1.02MSell
Sean MaduckOfficer2026-10-0215,843$116.12
$1.84MSell
Sean MaduckOfficer2026-10-0224,587$8.27
$203.33kBuy
Joseph Douglas LyonCTO;CAO2026-10-024,744$116.54
$552.87kSell

1 of 21

CORT insiders have bought more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when CORT insiders and whales buy or sell their stock.

CORT Shareholders

What type of owners hold Corcept Therapeutics Inc stock?

Institutional
Insider
Retail
NameHoldSharesValueType
Patrick G. Enright41.45%44,802,403$5.02BInsider
Bakker Juliet Tammenoms10.26%11,089,541$1.24BInsider
Longitude Venture Partners LP10.14%10,956,002$1.23BInsider
Alta Biopharma Partners II LP9.23%9,982,720$1.12BInsider
G. Leonard Baker Jr.8.73%9,440,067$1.06BInsider
Tench Coxe6.37%6,890,503$772.43MInsider
Joseph C. Cook Jr.6.26%6,765,805$758.45MInsider
David L. Anderson5.94%6,420,729$719.76MInsider
William H. Younger Jr.5.88%6,353,537$712.23MInsider
Joseph K. Belanoff5.78%6,248,596$700.47MInsider

1 of 3

CORT vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
CORT0.04%99.96%Net BuyingNet Selling
SMMT0.01%99.99%Net Buying
BBIO0.10%56.78%Net SellingNet Selling
TECH0.11%2.55%Net SellingNet Selling
JAZZ0.04%99.96%Net SellingNet Selling
View Top Biotech Stocks

Corcept Therapeutics Stock Ownership FAQ

Who owns Corcept Therapeutics?

Corcept Therapeutics (NASDAQ: CORT) is owned by 0.08% institutional shareholders, 179.51% Corcept Therapeutics insiders, and 0.00% retail investors. Patrick G. Enright is the largest individual Corcept Therapeutics shareholder, owning 44.80M shares representing 41.45% of the company. Patrick G. Enright's Corcept Therapeutics shares are currently valued at $5.22B.

If you're new to stock investing, here's how to buy Corcept Therapeutics stock.
©2026 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.